Enid N. Lam
305 Grattan Street
Melbourne, VIC 3000, Australia
Melbourne, VIC 3000, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Antigen reactivity defines tissue-resident memory and exhausted T cells in tumours.
Journal: bioRxiv : the preprint server for biology
Published: August 08, 2025
Antigen reactivity defines tissue-resident memory and exhausted T cells in tumors.
Journal: Nature immunology
Published: February 16, 2025
Catalytic inhibition of KAT6/KAT7 enhances the efficacy and overcomes primary and acquired resistance to Menin inhibitors in MLL leukaemia.
Journal: bioRxiv : the preprint server for biology
Published: December 23, 2024
Catalytic Inhibition of KAT6/KAT7 Enhances the Efficacy and Overcomes Primary and Acquired Resistance to Menin Inhibitors in MLL Leukemia.
Journal: Cancer discovery
Published: October 22, 2024
DOT1L provides transcriptional memory through PRC1.1 antagonism.
Journal: Nature cell biology
Published: February 12, 2024
CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunity.
Journal: Cell reports
Published: February 07, 2024
Comparative cofactor screens show the influence of transactivation domains and core promoters on the mechanisms of transcription.
Journal: Nature genetics
Published: November 30, 2023
SUMOylation enhances DNMT1 function to repress mega-intergenic RNAs and viral mimicry.
Journal: Nature genetics
Published: September 22, 2023
mRNA export factors store nascent transcripts within nuclear speckles as an adaptive response to transient global inhibition of transcription.
Journal: Molecular cell
Published: June 06, 2023
Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity.
Journal: Cancer discovery
Published: January 03, 2023
CRISPR-ChIP reveals selective regulation of H3K79me2 by Menin in MLL leukemia.
Journal: Nature structural & molecular biology
Published: January 03, 2023
CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunity.
Journal: Cell reports
Published: August 12, 2022
Last Updated: 09/26/2026